Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BIOA · NASDAQ · Pharmaceutical Preparations
$4.28−0.43 (−9.13%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Bioage Labs (BIOA) · oqro.io/stocks/BIOA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Cormorant Asset Management, LP cut its BIOA stake below 5% (4.9%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in BIOA for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ra Capital Management, L.P. disclosed an increased position in BIOA for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Ra Capital Management, L.P. disclosed a new position in BIOA for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed a reduced position in BIOA for Q1 2026SourceInsider trade · Traded Sep 27, 2024 · Filed Mar 10, 2025
Director purchased ~$54K of BIOA shares in the open marketSourceInsider trade · Traded Sep 27, 2024 · Filed Mar 10, 2025
Officer purchased ~$47K of BIOA shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Soros Fund Management no longer reported BIOA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. disclosed a reduced position in BIOA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed a reduced position in BIOA for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. disclosed an increased position in BIOA for Q4 2024Fund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Soros Fund Management disclosed a new position in BIOA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Montanova Capital, LLC disclosed a new position in BIOA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed a new position in BIOA for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Ra Capital Management, L.P. disclosed a new position in BIOA for Q3 2024Insider trade · Traded Oct 1, 2024 · Filed Oct 3, 2024
Director purchased ~$2.5M of BIOA shares in the open marketSourceInsider trade · Traded Oct 2, 2024 · Filed Oct 3, 2024
Director purchased ~$1.32M of BIOA shares in the open marketSourceInsider trade · Traded Oct 3, 2024 · Filed Oct 3, 2024
Director purchased ~$504K of BIOA shares in the open marketSourceInsider trade · Traded Sep 27, 2024 · Filed Oct 1, 2024
Insider purchased ~$8.1M of BIOA shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 12, 2025
a16z Capital Management, L.L.C. disclosed an increased position in BIOA for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
a16z Capital Management, L.L.C. disclosed a new position in BIOA for Q3 2024Source